Chronic Myelogenous Leukemia in Adults

We conduct sophisticated diagnostic tests such as chromosomal analysis to identify chronic myelogenous leukemia, a slow-growing cancer of the bone marrow and blood. We offer targeted chemotherapy that helps some people achieve long-term remission, in which cancer cells are no longer detected in the body. Stem cell transplantation is available for more aggressive cancer. We also provide psychosocial support to help you thrive during treatment for this chronic condition.

Clinical Trials and Research Studies

Phase 2

A Phase 2 study of WEE1 Inhibition with AZD1775 alone or combined with Cytarabine in Patients with advanced Acute Myeloid Leukemia Myelodysplastic Syndrome and Myelofibrosis

Learn More

Phase 1/2

Relapsed or Refractory Acute Myeloid Leukemia: Venetoclax and Alvocidib

Learn More

Phase 1

A Phase 1a/1b Dose Escalation and Expansion Trial of TTI-621 a Novel Biologic Targeting CD47 in Subjects with Relapsed or Refractory Hematologic Malignancies and Selected Solid Tumors

Learn More

Phase 1/2

AN OPEN-LABEL MULTICENTER PHASE l/1B TRIAL EVALUATING THE SAFETY ANDPHARMACOKINETICS OF ESCALATING DOSES OF BTCT4465A AS A SINGLE AGENT ANDCOMBINED WITH ATEZOLIZUMAB IN PATIENTS WITH RELAPSED OR REFRACTORYB-CELL NON-HODGKIN S LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA

Learn More